Welcome to Markets Desk, your midday read on the stories moving money and markets.
President Trump is doubling down on AI infrastructure, calling opposition to data centers a quote mistake and suggesting only the smart ones understand their value. The comments come as bipartisan pushback grows over community impact, energy demands, and local resistance — putting the White House squarely in the corner of big tech capital spending.
Shifting to aerospace, Archer Aviation is picking up three Boeing subsidiaries in exchange for a nineteen point seven five percent equity stake, a deal that reads as a genuine win on both sides of the ledger. Boeing sheds non-core assets and books a meaningful stake in the electric air taxi space, while Archer gains manufacturing capability and institutional credibility it would have taken years to build independently.
And on the pharma side, GSK received FDA acceptance with priority review status for a supplemental application covering its cancer drug Jemperli, targeting patients with previously untreated stage two and three mismatch repair deficient disease. Priority review designation compresses the FDA timeline and signals clinical urgency, which is meaningful for both patients and GSK's oncology pipeline valuation.
That's the tape. Markets Desk, signing off the floor.
